Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865281/0/en/Paratek-Pharmaceuticals-Presenting-New-Data-from-NUZYRA-Omadacycline-and-Investigator-Initiated-Pre-Clinical-Studies-at-European-Society-of-Clinical-Microbiology-Infectious-Disease.html
https://www.globenewswire.com//news-release/2024/03/05/2840253/0/en/Paratek-Pharmaceuticals-Announces-Positive-Efficacy-Data-for-NUZYRA-as-Post-Exposure-Prophylaxis-of-Inhalational-Anthrax-Triggering-Additional-Procurement-under-BARDA-Project-BioSh.html
https://www.globenewswire.com//news-release/2024/01/16/2809966/0/en/Paratek-Pharmaceuticals-Announces-Promotion-of-Jonathan-Light-to-General-Counsel-Corporate-Secretary-and-Chief-Compliance-Officer-and-Christopher-Bostrom-to-Chief-Financial-Officer.html
https://www.globenewswire.com//news-release/2023/12/13/2795577/0/en/Paratek-Pharmaceuticals-Announces-Inclusion-of-Oral-NUZYRA-in-China-s-National-Reimbursement-Drug-List.html
https://www.globenewswire.com//news-release/2023/10/05/2755325/33636/en/Paratek-Pharmaceuticals-to-Present-NUZYRA-Data-at-IDWeek-2023.html
https://www.reuters.com/markets/deals/novo-holdings-closes-462-mln-acquisition-paratek-pharmaceuticals-2023-09-21/
https://www.globenewswire.com//news-release/2023/09/21/2747312/33636/en/Gurnet-Point-Capital-and-Novo-Holdings-A-S-Complete-Acquisition-of-Paratek-Pharmaceuticals-Inc.html
https://www.globenewswire.com//news-release/2023/09/12/2741540/33636/en/Second-Leading-Independent-Proxy-Advisory-Firm-Glass-Lewis-Recommends-Paratek-Pharmaceuticals-Stockholders-Vote-FOR-the-Acquisition-by-Gurnet-Point-Capital-and-Novo-Holdings-A-S.html
https://www.globenewswire.com//news-release/2023/09/07/2739745/0/en/Leading-Independent-Proxy-Advisory-Firm-ISS-Recommends-Paratek-Pharmaceuticals-Stockholders-Vote-FOR-the-Acquisition-by-Gurnet-Point-Capital-and-Novo-Holdings.html
https://www.globenewswire.com/news-release/2023/08/02/2717520/33636/en/Paratek-Pharmaceuticals-Files-Definitive-Proxy-Statement-and-Letter-to-Stockholders-in-Connection-with-Acquisition-by-Gurnet-Point-Capital-and-Novo-Holdings.html